We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Image: ADLM 2026 takes place in Anaheim, California, from July 26 to 30

ADLM 2026 Explores Diabetes Milestones, Space Diagnostics, Alzheimer’s–Down Syndrome Links, and Cancer Advances

Five plenary sessions anchor ADLM's 2026 scientific program, highlighting advances spanning diabetes care, space diagnostics, neurodegenerative disease, cervical cancer screening, and cancer biomarkers. More...
24 Jul 2026
Image Credit: Adobe Stock

Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance

A new framework pairs rapid genotypic resistance testing with diversified therapies to improve gonorrhea cure rates. More...
24 Jul 2026
Image: The Prosigna test provides clinicians and patients with genomic insights to help make more informed breast cancer treatment decisions (Photo courtesy of Veracyte)

Genomic Test Helps Early Breast Cancer Patients Avoid Chemotherapy

New findings support a genomic assay that guides safe chemotherapy omission in many ER+/HER2-negative breast cancer patients. More...
24 Jul 2026
Image: Covering biopsies and excisions, the breast suite provides a fully IVDR-certified, end-to-end workflow across H&E, HER2, ER, PR, and Ki67-stained whole-slide images (Photo Courtesy of Ibex Medical Analytics)

AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer

An AI system gains CE-IVDR for breast IHC, standardizing ER/PR/Ki67 and HER2 scoring to improve precision and workflow efficiency. More...
24 Jul 2026
Image Credit: Adobe Stock

AI-Powered Genome Mapping Reveals New Layer of Alzheimer’s Disease Biology

AI combining 3D genome and spatial transcriptomics predicts gene activity linked to Alzheimer’s pathology. More...
23 Jul 2026
Image: Signatera is a personalized ctDNA-based MRD assay designed to detect relapse earlier than standard-of-care tools (Photo courtesy of Natera)

Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay

New findings show that Natera’s Signatera outperformed an antibody-based test in predicting Merkel cell carcinoma recurrence. More...
23 Jul 2026
Image from an introductory video for the GenPad cartridge being developed for the detection of Ebola virus disease (Bundibugyo virus). This product is currently under development and evaluation and is not intended for clinical use or commercial sale. A video introducing the development-stage platform is available at https://www.dnaform.jp/ja/GenPad/Product/BDBV Credit (Photo courtesy of Osaka Metropolitan University)

Portable Rapid Test Aims to Detect Ebola at Point of Care

A new portable isothermal NAAT to enable rapid Bundibugyo virus detection at point of care. More...
23 Jul 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
Immunofluorescence Analyzer
IFA System
Copyright © 2000-2026 Globetech Media. All rights reserved.